The association between concerns toward adverse reactions during pre-approval drug reviews and the post-approval addition of clinically significant adverse reactions to package inserts: A retrospective analysis of pre-approval drug review reports and safe

Ko Watanabe, Masayasu Murakami, Koichi Masuyama, Chieko Ishiguro, Tsutomu Matsuda
  • Pharmacoepidemiology and Drug Safety, September 2018, Wiley
  • DOI: 10.1002/pds.4662

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1002/pds.4662

In partnership with: